سعر بيتاجان Betagan‏ قطرة 5عين مل 0.5% 2026

Betagan 0.5% Eye Drops 5 Ml (5 mL bottle), antiglaucoma marketed in Egypt by Soficopharm.

• Transient ocular burning/stinging (up to 1 in 3), blepharoconjunctivitis (up to 1 in 20), decreased heart rate and blood pressure; rarely iridocyclitis, headache, ataxia, dizziness, lethargy, urticaria, pruritus.International label, same formulation · DailyMed (U.S. National Library of Medicine)

• Bronchial asthma or history of it, severe COPD, sinus bradycardia, second/third-degree AV block, overt cardiac failure, cardiogenic shock, hypersensitivity to any component.International label, same formulation · DailyMed (U.S. National Library of Medicine)

• May be absorbed systemically; the same adverse reactions as systemic beta-blockers may occur, including severe respiratory and cardiac reactions.International label, same formulation · DailyMed (U.S. National Library of Medicine)

• Oral beta-blockersPotential additive effects on IOP and systemic beta-blockade.DailyMed (U.S. National Library of Medicine)

• Fetotoxicity in rabbits at 200-700x the glaucoma dose; no teratogenicity in rats up to 1,800x; no adequate well-controlled studies in pregnant women; use only if benefit justifies risk to the fetus.International label, same formulation · DailyMed (U.S. National Library of Medicine)
• Unknown if excreted in human milk; systemic beta-blockers and topical timolol are; use with caution.International label, same formulation · DailyMed (U.S. National Library of Medicine)

• Levobunolol hydrochloride: Lowers intraocular pressure mainly by decreasing aqueous humour production.